Australia News Beep
  • News Beep
  • Australia
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Australia News Beep
Australia News Beep
  • News Beep
  • Australia
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

oncology

21 posts
SScience
Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC Cancer
Read More

Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC Cancer

  • September 20, 2025
Despite therapeutic advancements, the prognosis for metastatic ccRCC remains poor, with a 5-year survival rate of approximately 12–20…
HHealth
Early-onset pancreatic cancer patients benefit more from neoadjuvant chemotherapy and surgery
Read More

Oral microbiome linked to threefold higher pancreatic cancer risk

  • September 18, 2025
Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied…
SScience
Cancer Cells Dividing Illustration
Read More

“Rogue” DNA Rings Expose Brain Cancer’s Earliest Secrets

  • September 13, 2025
Scientists report that rogue rings of extrachromosomal DNA (ecDNA) can emerge strikingly early in glioblastoma and may set…
GGenetics
Colorful cancer ribbons as Health symbols for all types of cancers
Read More

Expanding Patient Access to Comprehensive Genomic Profiling

  • September 12, 2025
Comprehensive genomic profiling (CGP) is reshaping cancer care by enhancing diagnostic accuracy, informing prognosis, and enabling more personalized…
HHealth
What Is Cancer Cachexia? Causes, Symptoms, Diagnosis, and Treatment
Read More

What Is Cancer Cachexia? Causes, Symptoms, Diagnosis, and Treatment

  • September 9, 2025
IntroductionPathophysiology of cancer cachexiaClinical features and symptomsPrevalence and clinical impactDiagnosis and stagingManagement strategiesChallenges and research directionsConclusionsReferencesFurther reading Cancer…
HHealth
New approach doubles chemotherapy effectiveness by targeting cancer cell memory
Read More

NYU Langone strengthens world-leading GI cancer program with renowned leaders

  • September 6, 2025
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…
HHealth
New therapeutic approach targets undruggable protein driving aggressive breast cancer
Read More

Landmark study maps mutational landscape of triple-negative breast cancer in African American women

  • September 2, 2025
Triple-negative breast cancer (TNBC), the deadliest breast cancer subtype, disproportionately affects African American women – but until now,…
HHealth
Cancer Cells Dividing
Read More

Dementia-Like Behavior Discovered in Pre-Cancerous Cells

  • August 30, 2025
Researchers have uncovered a startling link between the mechanisms of dementia and the origins of pancreatic cancer, stemming…
AArtificial intelligence
Doctors’ skills get worse once they’ve used AI, warns Lancet study
Read More

Doctors’ skills get worse once they’ve used AI, warns Lancet study

  • August 20, 2025
As healthcare becomes smarter, will doctors become dumber? The rise of AI assistants that write consultation notes or…
HHealth
Neoadjuvant Immunotherapy Shows Promise in Limited-Stage SCLC
Read More

Neoadjuvant Immunotherapy Shows Promise in Limited-Stage SCLC

  • August 17, 2025
Small cell lung cancer: © Констянтин Батыльчук- stock.adobe.com Neoadjuvant immunotherapy combined with chemotherapy has demonstrated promising efficacy and…
HHealth
Study Reveals Missed Opportunities for Surgical Prevention of Ovarian Cancer
Read More

Study Reveals Missed Opportunities for Surgical Prevention of Ovarian Cancer

  • August 15, 2025
Illustration of ovarian cancer: © blueringmedia – stock.adobe.com One-fourth of patients with high-grade serous carcinoma (HGSC) may have…
TTechnology
Adjuvant Immunotherapy in High-Risk CSCC: Dr Koyfman’s KEYNOTE-630 Insights
Read More

Pembrolizumab Hits Nearly 90% Response Rate in Desmoplastic Melanoma

  • August 15, 2025
Melanoma: © David A Litman – stock.adobe.com Pembrolizumab (Keytruda) elicited a clinical response in nearly 90% of patients…
Australia News Beep
www.newsbeep.com